Alfredo Sanz-Medel-rekin lankidetzan egindako argitalpenak (9)

2017

  1. Effect of vanadium on calcium homeostasis, osteopontin mRNA expression, and bone microarchitecture in diabetic rats

    Metallomics, Vol. 9, Núm. 3, pp. 258-267

2014

  1. Changes in iron metabolism and oxidative status in STZ-induced diabetic rats treated with bis(maltolato) oxovanadium (IV) as an antidiabetic agent

    The Scientific World Journal, Vol. 2014

  2. Evaluation of the biological effect of Ti generated debris from metal implants: Ions and nanoparticles

    Metallomics, Vol. 6, Núm. 9, pp. 1702-1708

  3. Exposure to bis(maltolato)oxovanadium(IV) increases levels of hepcidin mRNA and impairs the homeostasis of iron but not that of manganese

    Food and Chemical Toxicology, Vol. 73, pp. 113-118

2013

  1. Aggravation by vanadium of magnesium deficiency in STZ-induced diabetic rats

    Magnesium Research, Vol. 26, Núm. 2, pp. 74-82

2012

  1. Absorption, transport and insulin-mimetic properties of bis(maltolato)oxovanadium (IV) in streptozotocin-induced hyperglycemic rats by integrated mass spectrometric techniques

    Analytical and Bioanalytical Chemistry, Vol. 402, Núm. 1, pp. 277-285

  2. Changes in the antioxidant defence and in selenium concentration in tissues of vanadium exposed rats

    Metallomics, Vol. 4, Núm. 8, pp. 814-819

  3. Effect of bis(maltolato)oxovanadium (IV) (BMOV) on selenium nutritional status in diabetic streptozotocin rats

    British Journal of Nutrition, Vol. 108, Núm. 5, pp. 893-899

2011

  1. Bioavailability, tissue distribution and hypoglycaemic effect of vanadium in magnesium-deficient rats

    Magnesium Research, Vol. 24, Núm. 4, pp. 196-208